Pharmaceuticals

Aminoglycosides Market Size and Demand Forecast 2026–2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the aminoglycosides market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Aminoglycosides Market?

The aminoglycosides market size has experienced strong growth in recent years. It is anticipated to expand from $1.91 billion in 2025 to $2.02 billion in 2026, at a compound annual growth rate (CAGR) of 5.8%. This historical expansion can be attributed to the high incidence of abdominal and urinary tract infections, widespread use of broad-spectrum antibiotics, conventional manufacturing processes, limited regulatory oversight in veterinary applications, and strong demand in ophthalmic solutions.

The aminoglycosides market is set for considerable expansion in the coming years, with its valuation expected to reach $2.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This projected growth throughout the forecast period is attributed to several factors such as intensified research and development in targeted aminoglycoside therapies, a growing recognition of antibiotic resistance, the implementation of advanced drug delivery systems, the expansion of the veterinary healthcare market, and the increasing application of personalized medicine. Key trends during this period also include the escalating prevalence of gram-negative infections, greater veterinary use of aminoglycosides, the creation of new aminoglycoside derivatives, a move towards injectable and targeted formulations, and the broadening of ophthalmic and inhalation applications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8515&type=smp

Which Drivers Are Supporting The Rise Of The Aminoglycosides Market?

A significant catalyst projected to advance the aminoglycosides market is the increasing frequency of animal disease outbreaks. An animal disease refers to a condition where an animal’s normal health is compromised, disrupting or altering its essential functions. Aminoglycosides, including amikacin and gentamicin, find widespread application in veterinary medical treatments. For example, as reported by GOV.UK, a UK-based government body, in July 2025, instances of lab-confirmed leptospirosis in England saw an increase from 70 in 2023 to 102 in 2024, indicating a 45.7% surge. Additionally, 890 cases of pasteurellosis were documented in 2024, up from 815 in 2023. Consequently, the escalating occurrence of animal disease outbreaks is set to fuel the growth of the aminoglycosides market.

What Segments Are Identified Within The Structure Of The Aminoglycosides Market?

The aminoglycosides market covered in this report is segmented –

1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products

2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral

3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases

What Trends Are Reshaping The Dynamics Of The Aminoglycosides Market?

Leading firms within the aminoglycosides market are concentrating on creating novel solutions, including enhanced manufacturing and formulation processes, to address the growing need for potent, advanced antibiotics effective against drug-resistant bacterial infections. Such improvements in processes lead to better purity, increased stability, and superior therapeutic efficacy when contrasted with conventional aminoglycoside synthesis techniques. As an illustration, in February 2024, Cipla Limited, an India-based pharmaceutical company, secured approval from the Central Drugs Standard Control Organization (CDSCO) for ZEMDRI (plazomicin), which is an intravenous aminoglycoside antibiotic, for use in India. This particular antibiotic is prescribed specifically for managing complicated urinary tract infections (cUTIs), encompassing pyelonephritis.

Which Leading Companies Dominate The Aminoglycosides Market Share?

Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience Limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc, Allergan PLC, Bristol Myers Squibb Company

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report

How Does The Aminoglycosides Market Perform Across Major Global Regions?

Asia-Pacific was the largest region in the aminoglycosides market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Aminoglycosides Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8515&type=smp

Browse Through More Reports Similar to the Global Aminoglycosides Market 2026, By The Business Research Company

Aminoglycosides Market Report 2026

https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report

Amino Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/amino-acid-global-market-report

Bionematicides Market Report 2026

https://www.thebusinessresearchcompany.com/report/bionematicides-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795